SCHEMBL7632157

SCHEMBL7632157

CC1=C(C)C(C)(C)C([Si](C)(C)C)=C1C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2353726 0.76
SCHEMBL2230540 0.71 CTSD (0.43) CTSD
SCHEMBL28961651 0.63 CTSD (0.38) CTSD
Hydrochloric Acid SCHEMBL819925 0.63 CTSD (0.33) CTSD
SCHEMBL14954053 0.63 CTSD (0.33) CTSD
Iodide SCHEMBL14953985 0.63 CTSD (0.33) CTSD
Bromide SCHEMBL14954363 0.63 CTSD (0.33) CTSD
Fluoride Ion SCHEMBL14953874 0.63 CTSD (0.33) CTSD
SCHEMBL2453426 0.61
SCHEMBL25223152 0.59 CTSD (0.35) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230118712-A1 Process for Preparing a Transition Metal Compound HANWHA SOLUTIONS CORPORAION (KR) 2023-04-20 US disclosed
EP-4122938-A1 PRODUCTION METHOD FOR TRANSITION METAL COMPOUND Hanwha Solutions Corporation (KR) 2023-01-25 EP disclosed
US-6465669-B1 MONOPROPYL OR MONOBUTYL-SUBSTITUTED RUTHENOCENE; USED FOR FORMING THIN FILM ELECTRODE MATERIAL USED IN SEMICONDUCTOR DEVICES AND PARTS. TANAKA KIKINZOKU KOGYO K.K. (JP) 2002-10-15 US disclosed
EP-0965602-B1 Groups 2 and 13 based catalyst composition for preparing high-syndiotacticity polystyrene from styrene or other acryl ethylene monomers and process using the same IND TECH RES INST (TW) 2002-05-02 EP disclosed
US-6211106-B1 Groups IIA and IIIA based catalyst composition for preparing high-syndiotacticity polystyrene INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2001-04-03 US disclosed
EP-1083161-A1 ORGANOMETALLIC COMPOUNDS FOR VAPOR-PHASE EPITAXY OF ORGANOMETAL Tanaka Kikinzoku Kogyo K.K. (JP) 2001-03-14 EP disclosed
EP-0965602-A1 Groups 2 and 13 based catalyst composition for preparing high-syndiotacticity polystyrene from styrene or other acryl ethylene monomers and process using the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1999-12-22 EP disclosed
US-5914375-A Catalyst composition for preparing high-syndiotactivity polystyrene from styrene or other aryl ethylene monomers and processes using the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1999-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230118712-A1 Process for Preparing a Transition Metal Compound INF2, ICMT, TMT1A CTSD 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.